The invention relates to benzimidazole sulfonamide derivatives of formula (I), the pharmaceutically acceptable addition salts thereof, the hydrates and/or solvates thereof, and the use of same as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma t). The invention also relates to pharmaceutical compositions comprising such compounds, as well as to the use thereof for the topical and/or oral treatment of ROR gamma t receptor-mediated inflammatory diseases, in particular acne, psoriasis and/or atopic dermatitis. Formula (I), X represents: Formula (II).